NeuroOne Ships Initial Zimmer Biomet Order For Its Evo SEEG System For Less Than 30 Day Use
NeuroOne Ships Initial Zimmer Biomet Order For Its Evo SEEG System For Less Than 30 Day Use
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) (NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it shipped the first commercial order to Zimmer Biomet for its Evo sEEG Electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain. Zimmer Biomet is the exclusive worldwide distribution partner for the NeuroOne Evo Cortical and sEEG electrode product lines.
NeuroOne医疗技术公司(纳斯达克股票代码：NMTC)(NeuroOne or本公司)是一家专注于改善神经系统疾病患者手术治疗选择和结果的医疗技术公司。该公司今天宣布，已向Zimmer Biomet公司发出了第一份商业订单，用于其Evo sEEG电极技术，暂时(不到30天)与记录、监测和刺激设备一起使用，用于记录、监测和刺激大脑地下水平的电信号。齐默生物科技是NeuroOne Evo Cortical和sEEG电极产品线的全球独家分销合作伙伴。
译文内容由第三方软件翻译。